Â鶹ÊÓƵAPK

Biography

Brian Skinner, PharmD, BCPS joined the clinical faculty as an Assistant Professor of Internal Medicine at Â鶹ÊÓƵAPK College of Osteopathic Medicine in June 2019. Dr. Skinner earned his Doctor of Pharmacy degree from Butler University in 2015. Along with attaining his degree, Dr. Skinner completed the Medical Spanish Track at Butler University in Indianapolis, Indiana. Subsequently, Dr. Skinner completed his residency training at St. Vincent Hospital Indianapolis. After completion of his residency, Dr. Skinner worked at Manchester University's College of Pharmacy where he concurrently served as one of the Internal Medicine Pharmacy Clinical Specialists at St. Vincent Hospital Indianapolis. At St. Vincent, Dr. Skinner provided education and training to a variety of learners including pharmacy students, MD/DO students, and medical residents. Dr. Skinner is certified by the Board of Pharmacy Specialties as a Pharmacotherapy Specialist. At Marian, Dr. Skinner provides pharmacology lectures to students enrolled in both the Doctor of Osteopathic Medicine program and the Master's of Biomedical Sciences program that bridge the gap between foundational science and clinical practice. 

Dr. Skinner's personal hobbies include collecting pharmacy antiques, playing piano, and spending time with his wife and daughter, along with their 4 cats and 2 dogs.

Publications

Young CM, Fahrholz CN, Manikowski KJ, Hum JM, Skinner BW. Drugs for Metabolic Bone Disease. In: Ray SD, ed. Slide Effects of Drug Annual: A worldwide yearly survey of new data in adverse drug reactions. Volume 44. Waltham, MA: Elsevier; 2022. (Chapter submitted).

Palmer A, Skinner BW. Aminoglycosides. In: Wexler P, ed. Encyclopedia of Toxicology, 4th Edition. Waltham, MA: Elseveir; 2022. (Accepted for publication, in-press).

Orr A, Kruse K, Vroegop J, Ausel E, Eland D, Turner J, Whitson C, Skinner BW, Hum J. High School student's perceptions of careers in healthcare and awareness of the osteopathic profession increase by participation in a healthcare camp [abstract]. J Osteopath Med. 2021;121(12):A47

Vincze J, Skinner BW, Tucker KA, Conaway K, Lowery JW, Hum JM. The Metabolic Bone Disease X-linked Hypophosphatemia: Case Presentation, Pathophysiology and Pharmacology. Life (Basel). 2021;11(6):563.

Rasool S, Skinner BW. Osilodrostat for the Treatment of Cushing's Disease. Expert Opin Pharmacother. 2021;22(9):1099-1106.

Kindler KJ, Skinner BW, Long J. Tobacco Bedside Education. In: ACCP Ambulatory Care Survival Guide, 4th edition; 2019.

Skinner BW, Morrical-Kline K. Interactions with Difficult Patients. In: ACCP Ambulatory Care Survival Guide, 4th edition; 2019.

Schoenle M, Skinner BW, Saum LM. Correlation between initiation or dose increase of central nervous system medications in inpatient falls [abstract]. Pharmacotherapy. 2018;38(7):e63-81.

Skinner BW, Goodhart AL, Curtis KA. Hypnotics and Sedatives. In: Ray SD, ed. Side Effects of Drug Annual: A worldwide yearly survey of new data in adverse drug reactions. Volume 40. Waltham, MA: Elsevier; 2018.

Skinner BW, Johnston EV, Saum LM. Benzodiazepine initiation and dose escalation. Ann Pharmacother. 2017; 51(4): 281-285.

Knaus SJ, Saum LM, Cochard E, Rupprecht C, Prichard W, Skinner BW, Medas R. Impact of evidence-based guidelines on outcomes of hospitalized patients with Clostridium difficile infection. South Med J. 2016;109(3):144-150.

Skinner BW, Medas R, Saum LM, Knaus S, Cochard E, Rupprecht C, Prichard W. Impact of evidence based guidelines for management of Clostridium difficile infection [abstract]. Pharmacotherapy. 2015;35(5):e66-95.